Skip to main content
. 2022 Sep 2;6(17):5132–5145. doi: 10.1182/bloodadvances.2022007334

Figure 1.

Figure 1.

Distribution of poor prognostic and frequently mutated genes in patients with higher-risk MDS by treatment arm. Mutational analysis was conducted on 270 bone marrow aspirate samples collected at screening (n = 135 samples from each treatment arm).